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Abstract  
Background: Hybrid Positron Emission Tomography and Magnetic Resonance (PET-
MR) allows the advantages of MR in tissue characterizing the myocardium to be 
combined with the unique metabolic insights of PET. We hypothesized that the area of 
reduced myocardial glucose uptake would closely match the area-at-risk (AAR) 
delineated by T2-mapping in ST-segment elevation myocardial infarction (STEMI) 
patients.  
Methods and results: Hybrid PET-MR using 18F-fluorodeoxyglucose (FDG) for 
glucose uptake was performed in 21 STEMI patients at a median of 5 days. Follow-up 
scans were performed in a subset of patients 12 months later. The area of reduced FDG 
uptake was significantly larger than the infarct size quantified by late gadolinium 
enhancement (LGE) (37.2±11.6% versus 22.3±11.7%; P<0.001), and closely matched 
the AAR by T2-mapping (37.2±11.6% versus 36.3±12.2%; P=0.10, R 0.98, bias 
0.9±4.4%). In the follow-up scans, the area of reduced FDG uptake was significantly 
smaller in size when compared to the acute scans (19.5 [6.3-31.8]% versus 44.0 [21.3-
55.3]%, P=0.002), and closely correlated with the areas of LGE (R 0.98) with a small 
bias of 2.0±5.6%. An FDG uptake of ≥45% on the acute scans could predict viable 
myocardium on the follow-up scan. Both transmural extent of LGE and FDG uptake 
on the acute scan performed equally well to predict segmental wall motion recovery. 
Conclusions: Hybrid PET-MR in the reperfused STEMI patient showed reduced 
myocardial glucose uptake within the AAR and closely matched the AAR delineated 
by T2-mapping. FDG uptake, as well as transmural extent of LGE acutely can identify 
viable myocardial segments.  
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INTRODUCTION  
In the first few days following an acute ST-segment elevation myocardial infarction 
(STEMI), cardiac magnetic resonance (MR) imaging can assess regional/global left 
ventricular function, myocardial infarct (MI) size, the ‘area-at-risk’ (AAR)1, 2, the 
presence of microvascular obstruction (MVO)3 and intra-myocardial hemorrhage4 - 
features which not only provide important prognostic information but may also serve 
as surrogate endpoints in cardioprotection studies. These omit a key biological 
parameter, cardiac metabolism, currently inaccessible by conventional MR imaging.  
The recent availability of hybrid Positron Emission Tomography and Magnetic 
Resonance (PET-MR) imaging offers the unique advantage of simultaneous tissue 
characterization by MR to be combined with the metabolic insights provided by PET, 
without requiring an acutely unwell patient to undergo two separate scans, and 
obviating complex and potentially imprecise co-registration of separately acquired PET 
and MR datasets. To date, there has been limited experience with hybrid PET-MR 
imaging of the heart5-8. T2-weighted MR imaging of myocardial edema has been used 
to quantify the AAR in STEMI patients, a pre-requisite for calculating myocardial 
salvage - a critical measure of efficacy in cardioprotection studies1, 9, 10. Hybrid PET-
MR imaging of the reperfused heart therefore, provides the opportunity to investigate 
cardiac metabolism in salvaged, reversibly injured myocardium within the AAR. The 
area of reduced myocardial glucose uptake has recently been shown to overestimate the 
AAR assessed by endocardial surface area (ESA).11 We hypothesized that the area of 
reduced myocardial glucose uptake would closely match the area-at-risk (AAR) 
delineated by T2-mapping in STEMI patients treated by PPCI. 
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METHODS 
Study population 
We performed a single-center study of 22 STEMI patients treated by PPCI recruited 
over a 7-month period. Study exclusion criteria were as follows: ≤45 years of age (to 
attenuate any theoretical higher risk from ionizing radiation in younger patients); 
diabetes mellitus (as pre-existing metabolic/glycemic derangement may affect clarity 
of initial results); previous MI; and standard recognized contraindications to MR. All 
eligible patients provided informed and written consent. The study was approved by 
the UK National Research Ethics Service.   
 
Hybrid PET-MR cardiac imaging protocol  
Patients underwent hybrid PET-MR imaging at a median of 5 [4-6] days after PPCI 
using an integrated whole-body PET-MR (3.0 Tesla) scanner (Biograph mMR, 
Siemens Healthcare, Erlangen, Germany)(Figure 1). A subset of patients underwent a 
follow-up scan at 12 months. 18F-fluorodeoxyglucose (FDG) was used to assess resting 
myocardial glucose metabolism. Subjects fasted for a minimum of 6 hours followed by 
75g of oral glucose 2 hours prior to the scan, and 45-60 minutes later, insulin was 
administered as previously described12, followed by intravenous FDG (mean activity 
of 248±15 MBq) at a mean of 73±12 minutes prior to PET images acquisition.  
A standard cardiac MR imaging protocol13 including cine imaging, and T2-mapping 
and late gadolinium enhancement (LGE) imaging performed simultaneously with the 
FDG-PET acquisition following single breath-hold attenuation correction (AC).  LGE 
imaging was performed using a standard segmented ‘fast low-angle shot’ two-
dimensional inversion-recovery gradient echo sequence 10-15 minutes after the 
injection of Gadoterate meglumine (Gd-DOTA marketed as Dotarem, Guerbet S.A., 
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Paris, France) at a dose of 0.1 mmol/kg and T2 maps (Works in Progress, software WIP 
#699, Siemens Healthcare, Frimley, UK) were acquired as previously described14. In 
brief, 3 single-shot images at different T2 preparation times (0ms, 24ms, and 55ms, 
respectively) using the following parameters were acquired: repetition time=3xR-R 
interval; acquisition matrix=116x192; flip angle=65°; slice thickness=6mm with 4mm 
gap; field of view adjusted according to subject size (320-400mm). Motion correction 
and fitting were performed to estimate coefficients of the decay function, which was 
subsequently used to estimate T2 relaxation times. An in-built specific color look-up 
table was used to output the final color T2 maps, consisting of pixel-wise T2 values. A 
full stack of short axis slices was acquired to cover the left ventricular (LV) from base 
to apex – each MR modality matching exactly the same slice position.   
FDG-PET images were acquired with one bed position, gated by electrocardiography, 
and comprised three-dimensional isotropic image reconstruction (voxel size, 2x2x2 
mm3) using Poisson ordered-subset expectation maximization with 21 subsets and three 
iterations, a Gaussian filter with 5.0-mm full-width at half maximum, and a 344x344 
image matrix to obtain summed average FDG-PET images. A four-compartment model 
PET attenuation map was calculated using the MR capabilities of the machine using 
fat-only and water-only Dixon-based sequences for automatic PET AC15.  
 
Image analysis 
Co-localization of the MI territory with FDG uptake 
Co-localization of the MI territory with FDG uptake was evaluated using ‘fused’ FDG-
LGE images created by fusing individual end-diastolic LGE short-axis slices with the 
summed static FDG-PET images using OsiriX freeware (Version 5.8.5, Geneva, 
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Switzerland). The fused images were then visually assessed to identify areas of LGE 
and reduced FDG uptake.  
 
Quantification of AAR, MI size and FDG uptake  
Quantification of LV volumes, LV mass, LV ejection fraction, AAR by T2-mapping, 
regions of reduced FDG uptake and MI size were performed using CVI42 software 
(Version 5.1.0, Calgary, Canada). As described above, each end-diastolic LGE slice 
was initially fused with the summed static FDG-PET images, extracting both a fused 
and a sliced-matched non-fused FDG image. These non-fused FDG LV short axis 
slices, along with their corresponding T2 maps were used for quantification. The 
epicardial and endocardial borders were first manually traced on the T2 maps and LGE 
images and copied onto the FDG images with minimal manual adjustment. The MI size 
was quantified by the Otsu-auto-thresholding (OAT) technique. Two blinded operators 
independently analyzed the T2 maps (OAT) and FDG-PET images (manual delineation 
of the regions with reduced FDG uptake on the summed images with visual 
optimization of the window settings by 2 operators).  Areas of MVO were included as 
part of the MI and AAR on the LGE images and T2 maps, and any obvious blood pool 
or pericardial partial voluming and artifacts manually corrected. One operator 
subsequently used OAT, Full Width Half Maximum and reduction in signal intensity 
2, 3, 4 and 5 standard deviations (SD) from the remote myocardium to quantify the 
regions of reduced FDG uptake. All of the LV short axis slices from base to apex were 
analyzed and the final extent of abnormal myocardium was expressed as a percentage 
of the LV volume. Polar maps for the FDG images were generated (Xeleris Version 
3.0, GE Healthcare, Milwaukee, Wisconsin) and displayed relative segmental FDG 
uptake as per the AHA model, normalized to the highest signal intensity for that patient 
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set at 100%. A second method to quantify the reduction in FDG uptake in the infarct-
related territory was also performed by using a threshold of <50% on the acute scan 
polar maps. A threshold of ≥50% on the follow-up polar maps was used for identifying 
viable segments.16 
Segmental analysis was performed using CVI42 software for early gadolinium 
enhancement (EGE), LGE and T2 maps and displayed according to the modified 16 
segment (excluding the apex) American Heart Association (AHA) model17.  The EGE 
images were visually analyzed by 2 experienced investigators and segments with a 
hypo-intense core were visually scored “0” or “1” for absence or presence of early 
MVO. Mean transmural extent of LGE was quantified for each short axis slice and 
mean segmental T2 values were also automatically generated displayed according to 
the modified 16 segments AHA model. Segmental wall motion analysis was visually 
performed by 2 experienced investigators and scored as “0” for normal; “1” for 
mild/moderate hypokinesis; “2” for severe hypokinesis; “3” for akinesis and “4” 
dyskinesis.18 A reduction in segmental wall motion score of ≥ 1 at follow-up was 
defined as an improvement in segmental wall motion.  
 
Coronary angiographic analysis 
Coronary angiograms were analyzed by 2 independent experienced investigators using 
the BARI (Bypass Angioplasty Revascularisation Investigation) and the modified 
APPROACH (Alberta Provincial Project for Outcome Assessment in Coronary Heart 
Disease) coronary angiography jeopardy scores19 to provide an MR-independent 
estimate of the AAR.  
 
Statistical analysis 
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Continuous data were expressed as mean±SD or median [interquartile range] for 
variables showing departure from a normal distribution. Categorical data were reported 
as frequencies and percentages. Intra-class correlation (ICC) coefficients for inter-
observer agreement20 were calculated for the T2-mapping and FDG-PET quantification 
by using single measures in a two-way random model for absolute agreement. Paired 
tests were used to compare measurements made within the same patient using 2 
techniques at 1 time point (e.g. AAR by T2-mapping and FDG-PET) or using the same 
technique at 2 time points (e.g. reduction in FDG uptake between the acute and follow-
up scans). Pearson’s correlation coefficient was used to assess inter-method correlation. 
Bland-Altman analysis was performed to assess agreement and bias detection between 
methods and presented as bias±2SD. Variances between methods were compared using 
Pitman’s test. Receiver Operating Characteristic (ROC) analyses were performed to 
assess the diagnostic performance for LGE, FDG and T2 on the acute scan for detecting 
viable myocardium and predicting segmental wall motion recovery. All statistical tests 
were two-tailed, and P <0.05 was considered statistically significant. Statistical analysis 
was performed using SPSS version 22 (IBM Corporation, Illinois, US). MedCalc 
version 15.6.1 (Medcalc Software Ostend, Belgium) was also used for ROC curve 
comparison using the method described by Delong et al21 and for correlation coefficient 
comparison described by Hinkle et al22. 
 
 
RESULTS 
21 patients completed the full imaging protocol at a median of 5 [4-6] days (1 patient 
was unexpectedly claustrophobic) - 76% were male and the median time between chest 
pain onset and PPCI was 247 [119-687] minutes. None of the patients had left bundle 
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branch block. More detailed patients characteristics and coronary angiographic details 
are presented in Table 1. 12 patients had a follow-up scan at a median of 12 (11-14) 
months following PPCI. 
 
Area of reduced FDG uptake is larger than MI size by LGE-MR 
From the fused FDG-LGE images, 20 out of 21 patients had reduced FDG uptake in 
the same territory of the MI location. The area of reduced FDG uptake was significantly 
larger than the area of LGE (37.2±11.6% with FDG-PET versus 22.3±11.7% with LGE-
MR; P<0.001)(Table 2). Figures 2 and 3 show representative images of patients with a 
transmural MI (minimal myocardial salvage) and a subendocardial MI (significant 
myocardial salvage), respectively.  
 
Area of reduced FDG uptake delineates the AAR by T2-mapping 
There was excellent per patient inter-observer agreement for the AAR by T2-mapping 
and manual delineation of reduced FDG uptake, with an ICC coefficient of 0.93 (95% 
CI 0.83-0.97; P<0.001) and 0.94 (95% CI 0.85-0.98; P<0.001), respectively. Figure 4 
and Table 3 show the performance of the different thresholding techniques when 
compared to manual delineation of the area of reduced FDG uptake. The 2 SD 
thresholding technique performed best with excellent correlation and agreement 
(P=0.07, ICC 0.99, R 0.99, bias of -0.9±4.33%), and was used for subsequent analyses. 
 The area of reduced FDG uptake closely matched the AAR delineated by T2-
mapping (37.2±11.6% with FDG-PET versus 36.3±12.2% with T2-mapping; P=0.10). 
There was an excellent correlation and agreement between the area of reduced FDG 
uptake and the AAR by T2-mapping (R 0.98, bias 0.9±4.4%, no difference between 
their variances, P=0.28) (Figure 5a and b). When using the 50% threshold on the polar 
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maps to quantify the area of reduced FDG uptake, there was no difference when 
compared with the AAR by T2-mapping (37.8±16.9% with FDG-PET versus 
36.3±12.2% with T2-mapping; P=0.10). The correlation between them was 0.90 but 
there was a wider limit of agreement on Bland Altman analysis (bias of 2.0±15.6%). 
Furthermore, Pitman’s test confirmed a difference in the AAR by the 2 methods 
(P<0.05). For patients with an AAR of < 35%, T2-mapping had a trend to give a higher 
AAR than FDG uptake whereas for an AAR of > 35%, T2 mapping tended to be lower 
that FDG uptake (Figure 5c and 5d). 
 
Area of reduced FDG uptake compared to BARI and modified APPROACH scores 
The area of reduced FDG uptake correlated well with the MR-independent estimates of 
the AAR using the BARI and modified APPROACH coronary angiography scores but 
overestimated the AAR (37.2±11.6% with FDG-PET versus 28.7±8.3% with BARI 
score, R 0.79, P<0.001 and bias of 8.4±14.2% and 37.2±11.6% with FDG-PET versus 
29.4±9.8% with APPROACH score, R 0.71, P<0.001 and bias of 8.7±17.2%, 
respectively).  
 
Hybrid cardiac PET-MR follow-up scans 
The area of reduced FDG uptake on the follow-up scans was significantly lower than 
those observed on the acute scans (Median [IQR]: 19.5 [6.3-31.8]% follow-up scan 
versus 44.0 [21.3-55.3]% acute scan, P=0.002), and correlated closely (R 0.98) with the 
areas of LGE on the follow-up scans. The area of reduced FDG uptake was more similar 
to the area of LGE on the follow-up scan (19.5 [6.3-31.8] FDG-PET versus 19.0 [2.0-
28.0]% LGE-MR, P=0.04, bias of 2.0±5.6%) (Figure 6) (Table 4). Figure 7 illustrates 
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the differences in FDG uptake between the acute and follow-up scans of two patients 
with different myocardial salvage. 
 
Reduced FDG uptake in the remote myocardium 
In one patient presenting with an acute inferior STEMI, there was an additional area of 
reduced FDG uptake in the remote myocardium within the non-obstructed left anterior 
descending (LAD) coronary artery, with the follow-up scan showing improved FDG 
uptake within this remote area (Figure 8).  This patient was excluded from any comparison 
given that there was reduced FDG uptake outside of the infarct-related territory.  
 
Acute scans to assess viability 
Using an FDG uptake of ≥50% to indicate viable myocardium on the follow-up scan, 
the transmural extent of LGE on both the acute scan (AUC on the ROC curve 0.93, 
95% CI 0.89 – 0.97) and the follow-up scan (AUC on the ROC curve 0.95, 95% CI 
0.92 – 0.99) performed equally well at predicting viable myocardium (P=0.13). Both 
acute LGE and follow-up LGE performed better than acute FDG uptake (AUC on the 
ROC curve 0.92, 95% CI 0.85 – 0.98) at detecting viable myocardium (P < 0.001 and 
P = 0.01 respectively for ROC curve comparison). The cut-off value of <50% 
transmural LGE on the acute scan had a sensitivity of 88% and specificity of 90% and 
on the follow-up scan had a sensitivity of 94% and specificity of 90%. The optimal cut-
off for FDG uptake on the acute scan was a value of ≥45%, giving a sensitivity of 85% 
and specificity of 95% to identify viable myocardium on follow-up. T2 performed the 
least well compared with LGE and FDG with an AUC of 0.79, 95% CI 0.71 – 0.87, and 
a cut-off value of 55ms had a sensitivity and specificity of 76%.  
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Segmental wall motion recovery 
Segmental wall motion was assessed in the 12 patients with acute and follow-up scans. 
4 segments were excluded (due to incidental chronic infarct). Out of the remaining 188 
segments, 94 segments (50%) had no wall motion abnormalities. The remaining 94 
segments had wall motion scores as follows: (1) 20 segments; (2) 23 segments; (3) 51 
segments. There was a similar correlation between wall motion score and FDG uptake 
on both the acute and follow-up scans (R -0.59 versus R -0.65, P 0.51). 
Out of 94 segments with abnormal wall motion, 19 segments (20%) had no LGE and 
had lower T2 values and higher FDG uptake than the 75 segments (80%) with the 
presence of LGE (T2: 48.9±5.1ms versus 57.2±8.1ms, P < 0.001; FDG uptake: 63±12 
versus 42±17, P < 0.001).  All segments with no LGE showed complete recovery of 
wall motion at one year. There was no correlation between the wall motion score and 
FDG uptake in these later segments (R -0.06, P=0.82). 
Among the segments with LGE, 34 segments (45%) had <50% transmural LGE and 41 
segments (55%) had ≥50% transmural LGE with no difference in T2 values between 
these 2 groups (T2: 55.7±8.1ms versus 58.4±7.9ms, P=0.18).  However, FDG uptake 
was significantly lower in segments with ≥50% transmural LGE (FDG uptake for 
LGE<50% 50±15 versus 35±16 for LGE>50%, P< 0.001) and these segments were also 
least likely to recover regional wall motion (LGE<50%: 27/34 – 79% recovered wall 
motion compared with LGE≥50% 20/41 – 49% recovered wall motion, P=0.006).   
All segments with early MVO had ≥50% transmural LGE.  When considering only 
segments with ≥50% transmural LGE, those with early MVO (n=20, 49%) had lower 
T2 values (consistent with intramyocardial hemorrhage - IMH) but similar level of FDG 
uptake compared with those without early MVO and these segments were also least 
likely to recover wall motion (T2: 55.4±5.9ms versus 62.0±8.6ms, P=0.01; FDG 
14 
 
uptake: 31±14 versus 39±17, P=0.09; wall motion recovery: 5/20 – 25% for those with 
early MVO versus 15/21 for those without – 75%, P=0.004).  
ROC curve analysis showed acute LGE and FDG performed equally well (AUC 0.82, 
95% CI 0.72 – 0.90 and 0.82, 95% CI 0.72 – 0.90, P=0.94) but better than T2 (AUC 
0.66, 95% CI 0.55 to 0.76, P=0.02 and P=0.04 respectively) to predict segmental wall 
motion recovery. 
 
DISCUSSION 
Using hybrid cardiac PET-MR imaging in reperfused STEMI patients, we found that 
the area of reduced myocardial glucose uptake by FDG-PET imaging closely matched 
the AAR delineated by T2-mapping. In STEMI patients with minimal myocardial 
salvage the areas of reduced FDG uptake were confined to the areas of LGE, confirming 
that cardiac metabolism was impaired within the irreversibly injured myocardium 
within the MI. However, in patients with significant myocardial salvage the areas of 
reduced FDG uptake extended beyond the areas of LGE and closely matched the AAR 
delineated by T2-mapping. This demonstrates that in patients with significant 
myocardial salvage impaired cardiac metabolism was not confined to areas of 
irreversibly injured myocardium within the MI, but also included the reversibly injured 
salvaged myocardium within the AAR. In a subset of patients who had 12 month 
follow-up scans, the areas of reduced FDG uptake were significantly lower than those 
observed on the acute scans, and were now confined to the areas of LGE only. This 
demonstrates normalization of cardiac metabolism within reversibly injured salvaged 
myocardium in the AAR, leaving areas of reduced FDG uptake in irreversible (non-
viable) tissue. 
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 The reliable and accurate measurement of the AAR is required to assess 
myocardial salvage in clinical studies investigating novel cardioprotective 
interventions in reperfused STEMI patients. Cardiac MR allows the retrospective 
delineation of the AAR in STEMI patients treated by PPCI, and depends on the ability 
of T2-weighted and T2-mapping to delineate the extent of myocardial oedema within 
the AAR23. It has been validated by histology in animal MI models24, 25, and by 
angiography jeopardy scores26 and myocardial SPECT imaging2, 27 in STEMI patients. 
An alternative method to estimate the AAR is to measure the ESA of LGE19. However, 
unlike T2-weighted and T2-mapping, ESA is unable quantify the AAR in patients with 
minimal or absent infarction.  Furthermore ESA has been shown to underestimate the 
AAR in STEMI patients when compared to T2-weighted imaging28. This finding was 
confirmed in a recent study11, in which the area of reduced FDG uptake was shown to 
over-estimate the AAR delineated by the ESA in reperfused STEMI patients.  
There is currently no gold standard method for accurately quantifying the 
reduction in FDG uptake, and so we used manual delineation by 2 blinded operators as 
our reference standard, and compared it to 6 other established thresholding techniques. 
In this study, we found that a 2SD thresholding technique performed best for 
quantifying the areas of reduced myocardial glucose uptake.  When using a threshold 
of 50% of peak – more conventional in the field of PET imaging – we found the limits 
of agreement between FDG-PET and T2 mapping were wide, likely due to the inherent 
differences in the 2 techniques used such as differences in spatial resolution and 
acquisition phase during the cardiac cycle.  
 The mechanism for the reduced FDG uptake observed in reversibly injured 
salvaged myocardium is not clear. Animal models have been used to elucidate the 
metabolic changes occurring in reversibly injured29, 30 and stunned myocardium31-33 but 
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due to the different ischemia/reperfusion protocols used and different baseline 
metabolic state of the animals prior to FDG administration,  results from these studies 
regarding glucose and free fatty acid metabolism varied. However, putting these studies 
into context, it may be plausible that the reversibly injured but stunned myocardium 
preferentially uptakes more glucose than free fatty acid following a period of fasting 
compared to the normal myocardium but has delayed glucose metabolism. Therefore, 
after an oral glucose load, the reversibly injured myocardium has a reduced FDG uptake 
but subsequently normalizes on the follow-up scan. 
  Although a threshold of ≥50% of FDG uptake has been used to identify viable 
myocardium in the setting of stable coronary artery disease (CAD), the utility of FDG 
uptake in the acute setting has not been extensively studied. We have provided further 
insights into the definition and performance of LGE and FDG to detect viability in the 
acute setting, using the FDG uptake on the corresponding follow-up scan as gold 
standard. Shirasaki et al34 has previously suggested a cut-off of 40% to detect viable 
myocardium, but FDG PET imaging was performed 2 weeks post AMI, and they used 
segmental wall motion recovery as the definition for viability. Rischpler et al8 used a 
cut-off of ≥50% in the acute setting but no follow-up FDG PET was performed for 
comparison. Therefore our study is the first to provide validation of FDG uptake in the 
acute AMI setting by using follow-up FDG as the gold standard for viability. 
 We have also provided important insights into segmental wall motion recovery 
following AMI. Dysfunctional segments without LGE showed increased edema and 
reduced glucose metabolism yet recovered completely. Dysfunctional segments with 
early MVO showed evidence of intramyocardial hemorrhage (IMH) and reduced 
glucose metabolism and were least likely to recovery wall motion. Segments with 
predominantly reversibly injured myocardium were equally edematous compared to 
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segments with predominantly irreversibly injury myocardium but differed in glucose 
metabolism. T2 did not perform as well as LGE and FDG on the acute scan to predict 
functional recovery due to the paramagnetic properties of IMH reducing the T2 signal.35 
Despite only having a small number of segments without LGE but with wall motion 
abnormality, the lack of correlation between FDG uptake and wall motion score may 
by reduction in wall thickening giving rise to reduced FDG uptake appearance on the 
summed static FDG images. 
 
Limitations of study 
There were a number of exclusions in our study (diabetics, age <45 years old, previous 
MI, known contraindications for MR) and our findings are limited to a selected group 
of STEMI patients. Being a low volume PPCI center and compounded by the strict 
inclusion criteria, we managed to recruit a small number of patients. Follow-ups were 
performed in 12 patients only but these were sufficient to confirm recovery of FDG 
uptake in salvage myocardium. Current techniques for PET AC are known to increase 
image noise, cause image distortion and artifacts and therefore manual adjustment of 
copied endocardial and epicardial contours, assisted by visual optimization of window 
settings was required. The significant difference between the paired scans (acute and 
follow-up) in 12 patients supports the study findings of a reduction in FDG uptake in 
the AAR within a week of an acute STEMI.  However, it is possible that by the use of 
summed static FDG-PET data, insufficient count recovery in stunned hypokinetic areas 
around the infarct border zone may have introduced an overestimation in the correlation 
between the FDG uptake and T2 mapping.  The development of techniques for PET-
MR cardiac phase registration, and partial volume correction, may improve future 
image analysis to confirm these findings.    
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Summary and conclusions 
We have demonstrated that the area of reduced myocardial glucose uptake in reversibly 
injured salvaged myocardium closely matched the AAR delineated by T2-mapping. 
Furthermore, FDG uptake, transmural extent of LGE and T2 values on the acute scan 
appear to predict subsequent myocardial viability and segmental wall motion recovery. 
With the advent of novel biological tracers, hybrid cardiac PET-MR has the potential to 
provide further insights into the pathophysiology of acute MI and subsequent post-MI LV 
remodeling.  
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Tables  
Table 1: Patients clinical characteristics and coronary angiographic details 
Details 
 
Number 
Number of patients 21 
 
Male  16 (76%) 
 
Age  59 ±10 
 
Previous coronary artery disease* 
 
2 (10%) 
 
Hypertension 8 (38%) 
 
Smoking 10 (48%) 
 
Dyslipidemia 4 (19%) 
 
Body Mass Index (kg/m2) 27.4±3.4 
 
Chest pain onset to PPCI time 
(minutes) 
 
247 [119-687] 
Infarct artery (%)  
              LAD 
                  Proximal  
                  Mid  
                  Distal  
              RCA  
                 Proximal  
                  Mid  
                  Distal  
 
13 (62) 
6 (46) 
6 (46) 
1 (8) 
8 (38) 
3 (37) 
2 (25) 
3(37) 
 
Pre-PPCI TIMI flow (%)  
              0 
              1 
              2 
              3  
 
16 (76) 
4 (19) 
1 (5) 
0 (0) 
 
Post-PPCI TIMI flow (%)  
              0 
              1 
              2 
              3 
 
1 (5) 
0 (0) 
2 (9) 
18 (86) 
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LAD: left anterior descending artery; RCA: right coronary artery; TIMI: thrombolysis in myocardial 
infarction; LV: left ventricle; SD: standard deviation; AAR: area at risk; ACEI/ARB: angiotensin 
converting enzyme inhibitor/ angiotensin receptor blocker. 
*not previously known – subtotal occlusions of obtuse marginal branches in both cases and 
subendocardial infarct on MR, in the absence of edema. 
 
Table 2: Hybrid PET-MR findings on acute scan 
 
Number of vessels 
             Single vessel disease 
             Double vessel disease 
 
16 (76) 
5 (24) 
 
AAR  
BARI score (% LV volume)  
APPROACH score (% LV volume) 
 
28.7±8.3 
29.4±9.8 
 
Treatment – during PPCI 
Aspirin 
Clopidogrel 
Ticagrelor 
Prasugrel 
Heparin 
Bivalirudin 
Glycoprotein IIbIIIa inhibitors 
Thrombectomy 
 
21(100%) 
1 (5%) 
18 (86%) 
2 (9%) 
14 (67%) 
14 (67%) 
11 (52%) 
17 (81%) 
 
Treatment – on discharge 
Dual antiplatelet therapy 
Beta blockers 
ACEI/ARB 
Statin 
Mineralocorticoid receptor antagonist 
Warfarin (apical thrombus) 
 
21(100%) 
20(95%) 
20(95%) 
21(100%) 
4(19%) 
4 (19%) 
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Characteristic Number 
 
Time from PPCI to hybrid PET-MR scan (days) 5 [4-6] 
 
Left ventricular ejection fraction (%)  50±11 (Normal range 58-76) 
 
End diastolic volume (ml) 138±22 (Normal range 113-196) 
 
Left ventricular mass (g) 150±46 (Normal range 107-184) 
 
Presence of MVO (%) 11 (46) 
 
Presence of apical thrombus (%) 4 (19) 
 
MI size by LGE MR (% LV volume) 22.3±11.7 
 
AAR by T2-mapping MR (% LV volume)  36.3±12.2 
 
AAR by FDG-PET (% LV volume) 
 
37.2±11.6 
 
Data are mean ± SD; PPCI: primary percutaneous coronary intervention; PET: positron emission 
tomography; MR: magnetic resonance; MVO: microvascular obstruction; MI: myocardial infarction; 
LGE: late gadolinium enhancement; AAR: area-at-risk; FDG: 18F-fluorodeoxyglucose 
 
 
 
Table 3: Quantifying the areas of reduced FDG uptake 
 
AAR by FDG-PET 
quantification 
P 
value 
ICC Correlation 
(R value) 
Bias±2SD 
Manual Other thresholds 
36.6±12.5 2SD: 37.2±11.6 0.07 0.99 0.99 -0.9±4.33 
36.6±12.5 3SD: 24.2±13.0 0.001 0.49 0.46 12.9±20.0 
36.6±12.5 4SD: 14.9±10.9 0.001 0.23 0.66 22.3±19.5 
36.6±12.5 5SD: 7.8±7.3 0.001 0.10 0.55 29.4±20.7 
36.6±12.5 FWHM: 38.5±19.2 0.61 0.74 0.80 -1.3±23.7 
36.6±12.5 Otsu: 41.7±12.0 0.09 0.53 0.55 -4.5±23.3 
AAR, area-at-risk; FDG-PET: 18F-fluorodeoxyglucose positron emission tomography. ICC intra-class 
coefficient 
*P values are for manual versus each threshold method 
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Table 4: Hybrid PETMR findings in 12 patients with acute and follow-up scans 
 Acute scan Follow-up scan P 
LVEF (%) 52 [47-59] 57 [47-68] 0.03* 
End diastolic volume (ml) 147 [126-159] 152 [133-168] 0.33 
Left ventricular mass (g) 150 [122-167] 110 [90-122] 0.002* 
MI size (% LV volume) 27.7 [8.1-35.5] 19.0 [2.0-28.0] 0.005* 
FDG-PET (% LV volume) 44.0 [21.3-55.3] 19.5 [6.3-31.8] 0.002* 
Data are median [Interquartile range]. * denotes statistical significance. 
LVEF: left ventricular ejection fraction; MI: myocardial infarction; FDG-PET: 18F-
fluorodeoxyglucose positron emission tomography. 
 
 
 
 
 
 
 
 
 
Figures legend 
Figure 1: The hybrid PET-MR cardiac imaging protocol  
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 (FDG: 18F-fluorodeoxyglucose; PET: Positron emission tomography; AC: Attenuation 
correction; EGE: Early gadolinium enhancement; LGE: Late gadolinium 
enhancement).  
Figure 2: Hybrid PET-MR cardiac imaging of transmural infarction  
A representative study patient with a distal LAD occlusion. Top panel: LGE-MR shows 
a transmural infarction confined to the LV apex and apical septum (red arrows); Upper 
middle panel: Corresponding FDG-PET images show areas of reduced FDG uptake 
matching those of infarction (white arrows); Lower middle panel: Corresponding T2 
mapping MR images showing areas of increased T2 values matching the areas of 
reduced FDG uptake (black arrows); Bottom panel: Corresponding fused LGE-MR and 
FDG-PET images showing co-localization of the area of infarction and reduced FDG 
uptake.  
Figure 3: Hybrid PET-MR cardiac imaging of subendocardial infarction  
Three study patients with subendocardial myocardial infarction (red arrows) with 
significant myocardial salvage. The areas of reduced FDG uptake (black arrows) and 
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the areas of edema on T2 maps (the AAR) (white arrows) extended both transmurally 
and radially beyond the areas of LGE.  
 
Figure 4: Quantifying the area of reduced FDG uptake using different 
thresholding techniques 
* denotes statistical significance. 
 
 
Figure 5: Correlation and agreement between reduced FDG uptake and the 
AAR delineated by T2-mapping (a & b using 2SD for reduction in FDG uptake 
quantification and c & d using a threshold of 50% on the polar maps).   
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Figure 6: Comparison of FDG uptake and LGE between the acute and 12 month 
follow-up hybrid cardiac PET-MR scans 
* denotes statistical significance 
 
 
Figure 7: FDG uptake in acute and follow-up hybrid cardiac PET-MR scans 
Representative LV short axis slices of FDG-PET and LGE-MR images in 2 STEMI 
patients with differing degrees of myocardial salvage. Patient A presented with an 
anterior STEMI and transmural myocardial infarction (red arrow) on the acute scan. On 
the follow-up scan there is no significant change in the area of reduced FDG uptake 
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confirming non-viable myocardium in the infarct zone. Patient B presented with an 
inferior subendocardial myocardial infarction (red arrow). The area of reduced FDG 
uptake is substantially larger than the area of LGE indicating significant myocardial 
salvage. On the follow-up scan there is a significant reduction in the area of reduced 
FDG uptake which is now restricted to the infarct zone.   
 
Figure 8: Reduced myocardial glucose uptake in remote myocardium  
One study patient with a mid-right coronary artery STEMI had an area of reduced FDG 
uptake (white arrow) matching the inferior infarct by LGE (red arrow) and the AAR in 
the inferior LV wall by T2-mapping (black arrow). There was an additional area of 
reduced FDG uptake in the anterior and antero-septal walls (yellow arrows) in remote 
myocardium. The follow-up scan showed improvement in FDG uptake in the anterior 
and antero-septal walls of the remote myocardium. 
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